Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KMS Medisurgi Ltd (BSE scrip code: 540468) has informed BSE that it is not required to submit a quarterly Corporate Governance report for the quarter ended 31 December 2025. The exemption is because the company is listed on the BSE SME Platform, and under SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulation 15(2), companies listed on the SME exchange are exempt from the corporate governance reporting requirements specified under Regulation 27(2). The letter was signed by Managing Director Siddharth Kanakia.
This is a routine regulatory compliance communication with no material impact on shareholders or the stock price. It simply confirms the company's exemption from quarterly corporate governance disclosures due to its SME listing status, which means investors will not receive a separate quarterly corporate governance report for this period.